Certified Pediatric Hematology Oncology Nurse (CPHON) 2025 – 400 Free Practice Questions to Pass the Exam

Question: 1 / 400

What is the usual prognosis for patients with Autoimmune Hemolytic Anemia?

Chronic and progressive

Usually transient and resolves spontaneously

The usual prognosis for patients with Autoimmune Hemolytic Anemia (AIHA) is that it is often transient and can resolve spontaneously. This condition occurs when the body's immune system mistakenly attacks its own red blood cells, leading to anemia. In many cases, especially in patients with primary AIHA or those associated with certain infections or medications, the hemolysis may self-resolve as the underlying trigger is addressed or naturally subsides.

Understanding the clinical context is crucial. While some cases may require treatment like corticosteroids or other immunosuppressive therapies, many patients eventually see improvement without invasive interventions. Hence, the overall tendency for AIHA to resolve on its own is a significant aspect of its prognosis, making the assertion that it is usually transient and resolves spontaneously correct.

Get further explanation with Examzify DeepDiveBeta

Requires lifelong treatment

Improves only with surgery

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy